Partial P2Y12 receptor blockade by clopidogrel may not be overcome by increasing the clopidogrel dose

被引：0
|
作者：
Judge, H. [1 ]
Buckland, R. [1 ]
Crosdale, D. [1 ]
Storey, R. F. [1 ]
机构：
[1] Univ Sheffield, CVRU, Sheffield, S Yorkshire, England
来源：
EUROPEAN HEART JOURNAL | 2005年 / 26卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：487 / 487
页数：1
相关论文
共 50 条
  • [41] Clopidogrel and Neuraxial Block The Role of the PFA II and P2Y12 Assays Reply
    Wu, Christopher L.
    Hanna, Marie N.
    REGIONAL ANESTHESIA AND PAIN MEDICINE, 2010, 35 (01) : 116 - 117
  • [42] Intrinsic platelet reactivity before P2Y12 blockade contributes to residual platelet reactivity despite high-level P2Y12 blockade by prasugrel or high-dose clopidogrel Results from PRINCIPLE-TIMI 44
    Frelinger, Andrew L., III
    Michelson, Alan D.
    Wiviott, Stephen D.
    Trenk, Dietmar
    Neumann, Franz-Josef
    Miller, Debra L.
    Jakubowski, Joseph A.
    Costigan, Timothy M.
    McCabe, Carolyn H.
    Antman, Elliott M.
    Braunwald, Eugene
    THROMBOSIS AND HAEMOSTASIS, 2011, 106 (02) : 219 - 226
  • [43] Residual platelet ADP reactivity after clopidogrel treatment is dependent on activation of both the unblocked P2Y1 and the P2Y12 receptor and is correlated with protein expression of P2Y12
    Braun, Oscar Oe
    Amisten, Stefan
    Wihlborg, Anna-Karin
    Hunting, Karen
    Nilsson, David
    Erlinge, David
    PURINERGIC SIGNALLING, 2007, 3 (03) : 195 - 201
  • [44] Efficacy of high maintenance dose of clopidogrel to overcome high post treatment platelet P2Y12 reactivity after drug eluting coronary stent implantation
    Ryu, J.
    Lee, Y.
    Lee, J.
    Choi, J.
    Kim, K.
    Chang, S.
    EUROPEAN HEART JOURNAL, 2010, 31 : 976 - 977
  • [45] Residual platelet ADP reactivity after clopidogrel treatment is dependent on activation of both the unblocked P2Y1 and the P2Y12 receptor and is correlated with protein expression of P2Y12
    Oscar Ö Braun
    Stefan Amisten
    Anna-Karin Wihlborg
    Karen Hunting
    David Nilsson
    David Erlinge
    Purinergic Signalling, 2007, 3 : 195 - 201
  • [46] Hunting for the "Sweet Spot" in P2Y12 Receptor Blockade
    Simon, Daniel I.
    Parikh, Sahil A.
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2009, 54 (15) : 1447 - 1449
  • [47] Monitoring platelet inhibition induced by P2Y12 receptor blockade:: A comparison of P2Y12 specific assays
    Angiolillo, Domiaick J.
    Desai, Bhaloo
    Hang, Yuan
    Charlton, Ronald
    Bernardo, Esther
    Shoemaker, Steven
    Zenni, Martin
    Guzman, Luis
    Gilmore, Paul
    Bass, Theodore A.
    Costa, Marco A.
    AMERICAN JOURNAL OF CARDIOLOGY, 2006, 98 (8A): : 205M - 206M
  • [48] Assessment of P2Y12 inhibition with the point-of-care device VerifyNow P2Y12 in patients treated with prasugrel or clopidogrel coadministered with aspirin
    Varenhorst, Christoph
    James, Stefan
    Erlinge, David
    Braun, Oscar O.
    Brandt, John T.
    Winters, Kenneth J.
    Jakubowski, Joseph A.
    Olofsson, Sylvia
    Wallentin, Lars
    Slegbahn, Agneta
    AMERICAN HEART JOURNAL, 2009, 157 (03) : 562.e1 - 562.e9
  • [49] Characteristics and safety outcomes in first-time users of the P2Y12 receptor antagonists clopidogrel, prasugrel and ticagrelor
    Linder, M.
    Johansson, S.
    Himmelmann, A.
    Andersen, M.
    EUROPEAN HEART JOURNAL, 2016, 37 : 380 - 380
  • [50] Clopidogrel, a P2Y12 Receptor Antagonist, Potentiates the Inflammatory Response in a Rat Model of Peptidoglycan Polysaccharide - Induced Arthritis
    Garcia, Analia E.
    Mada, Sripal R.
    Rico, Mario C.
    DeLa Cadena, Raul A.
    Kunapuli, Satya P.
    BLOOD, 2011, 118 (21) : 1413 - 1413
12345